Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 7 | 2010 | 46 | 1.290 |
Why?
|
| Endothelial Cells | 8 | 2014 | 59 | 1.240 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 7 | 2010 | 36 | 0.840 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2007 | 26 | 0.790 |
Why?
|
| Lysophosphatidylcholines | 4 | 2007 | 8 | 0.770 |
Why?
|
| Signal Transduction | 9 | 2014 | 446 | 0.770 |
Why?
|
| rhoA GTP-Binding Protein | 3 | 2008 | 9 | 0.750 |
Why?
|
| Catenins | 2 | 2011 | 2 | 0.710 |
Why?
|
| Capillary Permeability | 4 | 2006 | 29 | 0.590 |
Why?
|
| Up-Regulation | 2 | 2012 | 175 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 54 | 0.400 |
Why?
|
| Cells, Cultured | 10 | 2010 | 524 | 0.370 |
Why?
|
| Transcription Factors | 2 | 2010 | 166 | 0.330 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2008 | 2 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 95 | 0.290 |
Why?
|
| Carrier Proteins | 3 | 2004 | 98 | 0.290 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2007 | 2 | 0.270 |
Why?
|
| Monocytes | 1 | 2007 | 61 | 0.260 |
Why?
|
| Thrombin | 4 | 2014 | 15 | 0.260 |
Why?
|
| Animals | 12 | 2010 | 3625 | 0.250 |
Why?
|
| Cyclic AMP | 5 | 2008 | 32 | 0.240 |
Why?
|
| Protein Kinase C | 1 | 2005 | 48 | 0.230 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 272 | 0.230 |
Why?
|
| Brain | 4 | 2011 | 1648 | 0.220 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 17 | 0.210 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 42 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 37 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 190 | 0.190 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 81 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2002 | 50 | 0.190 |
Why?
|
| High Mobility Group Proteins | 1 | 2001 | 3 | 0.190 |
Why?
|
| Genistein | 2 | 2012 | 5 | 0.180 |
Why?
|
| Humans | 17 | 2014 | 27125 | 0.170 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 107 | 0.170 |
Why?
|
| Cell Line | 4 | 2011 | 271 | 0.170 |
Why?
|
| Cattle | 3 | 2010 | 124 | 0.150 |
Why?
|
| Pulmonary Artery | 3 | 2011 | 34 | 0.150 |
Why?
|
| Skin | 3 | 2005 | 126 | 0.150 |
Why?
|
| Phosphorylation | 5 | 2012 | 147 | 0.140 |
Why?
|
| COS Cells | 2 | 2008 | 39 | 0.140 |
Why?
|
| Gene Silencing | 2 | 2011 | 24 | 0.140 |
Why?
|
| Inflammation | 2 | 2011 | 274 | 0.130 |
Why?
|
| Mutation | 2 | 2008 | 350 | 0.130 |
Why?
|
| Transfection | 2 | 2008 | 121 | 0.120 |
Why?
|
| Gene Expression | 3 | 2006 | 200 | 0.120 |
Why?
|
| Retina | 1 | 2014 | 8 | 0.110 |
Why?
|
| Serine | 3 | 2012 | 10 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 5 | 0.110 |
Why?
|
| Dermis | 2 | 2006 | 9 | 0.110 |
Why?
|
| Electric Impedance | 2 | 2005 | 26 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2012 | 11 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2005 | 15 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 39 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2014 | 49 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2014 | 114 | 0.110 |
Why?
|
| Phytoestrogens | 1 | 2012 | 4 | 0.100 |
Why?
|
| Aorta | 1 | 2012 | 17 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2003 | 310 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 117 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 100 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2010 | 12 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2010 | 23 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 44 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2010 | 38 | 0.080 |
Why?
|
| Insulin | 1 | 2010 | 91 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 131 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2010 | 179 | 0.080 |
Why?
|
| Adenoviridae | 3 | 2004 | 16 | 0.080 |
Why?
|
| Hemostatics | 2 | 2014 | 11 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 320 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 129 | 0.080 |
Why?
|
| Serum Response Element | 1 | 2008 | 1 | 0.080 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2008 | 2 | 0.080 |
Why?
|
| Consensus Sequence | 1 | 2008 | 2 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 20 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 30 | 0.080 |
Why?
|
| Protein Binding | 1 | 2008 | 126 | 0.070 |
Why?
|
| Cell Survival | 2 | 2005 | 119 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2005 | 118 | 0.070 |
Why?
|
| Myosin Light Chains | 1 | 2007 | 3 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Lung | 2 | 2005 | 168 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 7 | 0.070 |
Why?
|
| Retroviridae | 1 | 2007 | 5 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 21 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2006 | 11 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2006 | 68 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 4 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2005 | 8 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2005 | 7 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 65 | 0.060 |
Why?
|
| Sphingosine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Phosphorylcholine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Rabbits | 2 | 2004 | 180 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 33 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 25 | 0.060 |
Why?
|
| Lung Injury | 1 | 2004 | 10 | 0.060 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2004 | 4 | 0.060 |
Why?
|
| Colforsin | 1 | 2004 | 12 | 0.060 |
Why?
|
| Rolipram | 1 | 2004 | 3 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2004 | 12 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2004 | 5 | 0.060 |
Why?
|
| Albuterol | 1 | 2004 | 15 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2004 | 86 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2004 | 44 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 91 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 75 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 29 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2003 | 33 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 144 | 0.050 |
Why?
|
| Ion Channels | 1 | 2004 | 207 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 45 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2002 | 12 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 275 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 34 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 9 | 0.050 |
Why?
|
| Introns | 1 | 2001 | 17 | 0.050 |
Why?
|
| Luciferases | 1 | 2001 | 25 | 0.050 |
Why?
|
| Exons | 1 | 2001 | 33 | 0.050 |
Why?
|
| Base Sequence | 1 | 2001 | 106 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 118 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 192 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 383 | 0.040 |
Why?
|
| Antioxidants | 2 | 2010 | 66 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 31 | 0.030 |
Why?
|
| Rats | 2 | 2007 | 660 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 78 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 41 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 72 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 16 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 22 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2010 | 21 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 55 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 374 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 148 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 433 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 7 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2007 | 7 | 0.020 |
Why?
|
| Swine | 1 | 2007 | 73 | 0.020 |
Why?
|
| Mice | 1 | 2010 | 1414 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 3 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 3 | 0.010 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 10 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2005 | 15 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 2005 | 3 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 82 | 0.010 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 3 | 0.010 |
Why?
|
| Pulmonary Surfactants | 1 | 2004 | 6 | 0.010 |
Why?
|
| Radiation Pneumonitis | 1 | 2004 | 4 | 0.010 |
Why?
|
| Epithelium | 1 | 2004 | 28 | 0.010 |
Why?
|
| Endothelium | 1 | 2004 | 14 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 46 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 23 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2004 | 1 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2004 | 6 | 0.010 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 4 | 0.010 |
Why?
|
| Sarcolemma | 1 | 2004 | 7 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 46 | 0.010 |
Why?
|
| Diterpenes | 1 | 2004 | 4 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2004 | 5 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2004 | 13 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 76 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 81 | 0.010 |
Why?
|
| Feedback | 1 | 2004 | 33 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 98 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 180 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 183 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Tritium | 1 | 2004 | 8 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2004 | 16 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 14 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 35 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 19 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 30 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 107 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2002 | 2 | 0.010 |
Why?
|
| Lymphokines | 1 | 2002 | 10 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 15 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 11 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 9 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 7 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 35 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 55 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2002 | 157 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 60 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 600 | 0.010 |
Why?
|
| Male | 1 | 2010 | 14801 | 0.010 |
Why?
|